Clinical Trial

Facilitating Autism Diagnosis in Shorter Timeframes by PCCs

Study acronym: FAST-ASD
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
This study is looking at time to diagnostic resolution for children ages 18-36 months with concern of ASD. The main purpose of this research study is to see if the time between when a child aged 18-36 months fails an autism screen or a clinician raises concern and is evaluated is shorter in the primary care practices where the clinicians have been trained to conduct diagnostic evaluations. The training includes use of the Childhood Autism Rating Scale-2, which is validated for use in children 2 and older. The investigators also want to learn more about whether primary care clinicians can accurately evaluate and diagnose young children ages 18-36 months of age with autism spectrum disorder (ASD).
Trial Details
NCT Number NCT07458633
Lead Sponsor Boston Children's Hospital
Collaborators: Boston Medical Center, Baylor College of Medicine, Children's Hospital of Philadelphia, Children's Hospital Medical Center, Cincinnati
Conditions Autism Spectrum Disorder
Enrollment 300 participants
Start Date 2026-03-01
Primary Completion 2027-10-01 (estimated)
Study Completion 2027-10-01 (estimated)
Updated on ClinicalTrials.gov 2026-03-09